IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 174 filers reported holding IMPAX LABORATORIES INC in Q2 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $26,978,000 | +11.2% | 1,387,017 | -4.8% | 0.03% | +10.7% |
| Q4 2017 | $24,252,000 | +35.0% | 1,456,376 | +64.5% | 0.03% | +27.3% |
| Q3 2017 | $17,970,000 | +33.4% | 885,238 | +5.8% | 0.02% | +29.4% |
| Q2 2017 | $13,475,000 | +21.2% | 836,936 | -4.8% | 0.02% | +21.4% |
| Q1 2017 | $11,120,000 | +401.1% | 879,085 | +1041.8% | 0.01% | +366.7% |
| Q2 2016 | $2,219,000 | +10.4% | 76,988 | +22.7% | 0.00% | 0.0% |
| Q1 2016 | $2,010,000 | -16.0% | 62,765 | +12.1% | 0.00% | 0.0% |
| Q4 2015 | $2,394,000 | +22.2% | 55,998 | +0.7% | 0.00% | 0.0% |
| Q3 2015 | $1,959,000 | -94.9% | 55,632 | -93.2% | 0.00% | -92.7% |
| Q1 2015 | $38,416,000 | +266.0% | 819,619 | +96.3% | 0.04% | +272.7% |
| Q4 2013 | $10,497,000 | +24.3% | 417,550 | +1.2% | 0.01% | +120.0% |
| Q3 2013 | $8,447,000 | – | 412,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |